Ekso Bionics updates reverse stock split effective date to June 2, 2025

EKSO BIONICS HOLDINGS, INC.

Reverse stock split at 1-for-15 effective June 2, 2025; originally planned May 27.
Approved by shareholders on May 16; aims to regain Nasdaq $1.00 minimum bid price.
Pre-split shares ~35.5M; post-split ~2.4M outstanding; fractional shares rounded up.
Common stock to trade on Nasdaq under symbol EKSO on split-adjusted basis.
New CUSIP number 282644 400 will apply after the split.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.